Home › Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst
 

Keywords :   


Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst

2015-10-13 08:51:01| Biotech - Topix.net

Alimera Sciences is a bio-pharmaceutical company on the Nasdaq with a market cap of $116 million. The company has developed a product called Iluvien , which was FDA approved in 2014 and made commercially available in the US, UK, Germany and Portugal.

Tags: stock buying sciences sees

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Forecast Discussion Number 9
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 19
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 9
More »